Join
Live feed
·
PRReleasevia Quantisnow
Gracell Biotechnologies Inc. logo

Gracell Biotechnologies Reports Fourth Quarter and Full Year 2022 Unaudited Financial Results, and Provides Corporate Update

ByQuantisnow·Wall Street's wire, on your screen.
GRCL· Gracell Biotechnologies Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track GRCL (Gracell Biotechnologies Inc.) and more on Quantisnow.